Press Releases

STAMFORD, Conn. & NEW YORK--(BUSINESS WIRE)-- Scientists from the Icahn School of Medicine at Mount Sinai, Eli Lilly and Company, and Sema4 released results from a proof-of-concept study demonstrating that patient-derived cells offer a more effective approach for assessing drug response than conventional methods. These findings could pave the way for streamlined drug discovery, particularly for diseases suc

NEW YORK--(BUSINESS WIRE)-- CYBERGYM, a global network of cyber-warfare qualification and training arenas, today announced a timely program to train organizations on ho

VERNAL, Utah--(BUSINESS WIRE)-- Superior Drilling Products, Inc. (NYSE American: SDPI), a designer and manufacturer of drilling tool technologies, today announced

DUBLIN--(BUSINESS WIRE)-- Allegion plc (NYSE: ALLE), a leading global provider of security products and solutions, today reported third-quarter 2018 net r

PALO ALTO, Calif.--(BUSINESS WIRE)-- Science Exchange, the leading marketplace for outsourced R&D, and Certis Oncology, a leading pro

MANASSAS, Va.--(BUSINESS WIRE)-- Medliminal, a medical bill review company that offers clients focused, innovative and cost-saving solutions through cutting edge technology, announced a strategic alliance with Koehler Fitzgerald Law, a technology-driven Cleveland, Ohio based law firm. Leading the healthcare industry as a medical cost containment company, Medliminal offers solutions through its Roboti

DOVER, Del.--(BUSINESS WIRE)-- Dover Motorsports, Inc. (NYSE: DVD) today reported results for the three months ended September 30, 2018. Our fall 2018 NASCAR event weekend, which consisted of a K&N Pro Series East event, an XFINITY Series event, and a Monster Energy Cup Series event, was held entirely in the fourth quarter of 2018. The 2017 race weekend was held from September 29 to October 1, 20

LONDON--(BUSINESS WIRE)-- nVent Electric plc (NYSE:NVT) (“nVent”), a global leader in electrical connection and protection solutions, today announced financial results for the third quarter of 2018 and provided guidance for the fourth quarter and full-year 2018. Third quarter sales of $564 million grew 4 percent relative to the third quarter 2017 and grew 5 percent organically, which excl

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the third quarter of 2018 which were highlighted by strong sales and opera

RALEIGH, N.C.--(BUSINESS WIRE)-- Merz today announced long-term results from a Phase 3 extension study of XEOMIN® (incobotulinumtoxinA) for the treatment of adults with chronic sialorrhea, also known as excessive drooling. Results were presented at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly being held October 25-28 in Orlando, FL. I

DUBLIN--(BUSINESS WIRE)-- Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the following conferences in November: Stifel 2018 Healthcare Conference Date: Wednesday, Nov. 14, 2018 Presentation Time: 10:15 a.m. EST

MAPLE PLAIN, Minn.--(BUSINESS WIRE)-- Proto Labs, Inc. (NYSE: PRLB), a leading online and technology-enabled, quick-turn, on-demand manufacturer, today announced financial results for the third quarter ended September 30, 2018. Third Quarter 2018 Highlights include: Revenue for the third quarter of 2018 was a record $115.4 million, representing a 31.

IRVINE, Calif.--(BUSINESS WIRE)-- Kerrigan Advisors, the leading sell-side advisory firm to auto dealers in the US, today announced that it has opened a second office in the Washington DC metro to better serve its client base across the US. Heading up the new office is automotive retail real estate veteran Gabriel (Gabe) Robleto, who has been named Kerrigan Advisors’ Vice President of Buy/Sell Advisory. R

SAN FRANCISCO & SHANGHAI--(BUSINESS WIRE)-- Innovusion, a leading developer of LiDAR technology for the autonomous vehicle markets, today announced it has raised about US $

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease, today announced that Robert Copeland, PhD, and Kimi Iguchi, CPA, have joined its board of directors. “We are thrilled that Kimi and Bob have joined us as we develop therapies for p